The Yield Growth Corp. Keeps Growing Like a Weed…or a Mushroom
November 26th, 2019
App, Exclusive, News, Top News
While some companies are scratching their heads about what to make of the brutal treatment cannabis stocks have felt this year, The Yield Growth Corp. (CSE: BOSS)(OTCQB: BOSQF) seems undaunted, expanding its cannabis business while rapidly emerging as a leading public company in the mushroom space.
The upstart has assembled a management team rich with branding experience earned at companies like Procter & Gamble, Johnson & Johnson, Skechers, Best Buy and M·A·C Cosmetics to build new brands employing old world therapeutics for modern-day ailments.
A Global Hemp Brand
Yield Growth owns the cannabis wellness brands Urban Juve, Wright & Well and Jack n Jane. As hemp-based CBD-based beauty products make their way into the mainstream, Urban Juve, has been featured in popular publications globally, including UK Vogue, Vanity Fair UK and Elle Canada. The timing of the media exposure couldn’t be better with Urban Juve products spreading across more than 8,000 retail locations in Canada, Colombia, Brazil, Greece and Cyprus.
To the point of Greece, a distribution agreement with Melorganics kicked off this month, sending about 2,500 Urban Juve products to the cradle of Western civilization. Meloraganics is responsible for distribution in Greece and Cyprus and with the pact freshly amended, Romania, Bulgaria and Serbia have been added to the list.
Urban Juve and Melorganics have moved swiftly to now have 11 Urban Juve products registered in the European Union. With the addition of Romania, Bulgaria and Serbia, Melorganics has committed to place the first purchase order for Urban Juve products for these territories by the end of the year.
At this time, Urban Juve is the primary revenue driver for Yield Growth, so these new sales regions will be important to continue the steep growth trajectory the company is on. During the third quarter, revenue was $1.9 million, a big leap from about $400,000 a year earlier.
Trendy Mushrooms, Magic and Not
Mushrooms are being called by some “the new cannabis,” evoking memories of where the cannabis space was a decade ago before the so-called pot stock boom. Yield Growth has moved with a purpose in this field lately, establishing Flourish Mushroom Labs as a subsidiary and making acquisitions that stockpiled the new company with over 130 mushroom recipes for a variety of consumer goods, such as teas, soups and coffees.
Flourish Labs intends to initially focus on mushroom coffee, with intentions for the first coffee mix product to be launched in the coming months.
It’s important to recognize that while “magic” mushrooms, those that contain the psychedelic psilocybin, are certainly part of the equation, they are a smaller part of the strategy right now. Many experts have opined that psilocybin has great potential to treat a number of difficult diseases and conditions, such as depression, anxiety and post-traumatic stress disorder, but being a Schedule I drug at the federal level has severely limited clinical research to validate the anecdotal evidence.
Recently, Denver and Oakland decriminalized magic mushroom and reports are that Santa Cruz and Chicago are strongly considering changing their laws as well, perhaps signaling the start of the shift towards legal magic mushrooms much in the same way cannabis and its derivatives have been steadily legalized. Flourish will explore the psychedelic mushroom opportunity as it goes headlong into the functional mushroom space, as many of the product formulas could simply replace one type of functional mushroom with one containing psilocybin as a therapeutic.
Functional mushrooms are quietly surging in popularity amongst hipsters and health-conscious individuals. These mushrooms – which have names like Lion’s Mane, Turkey Tail, Reishi, Shitake, Chagas and Cordyceps – do not have any psychoactive effect, but they have, however, been lauded for a wide spectrum of health benefits ranging from boosting the immune system to lowering cholesterol.
Boomin’ Mushroom Market
Market intelligence firm Mordor Intelligence forecasts the functional mushroom market to grow from $5.8 million in 2018 by 6.4% annually through 2024.
Whole Foods named functional mushrooms as a top food trend for 2018. Apropos, super powders were also named as a top food trend, including the mention of rising use of ground turmeric powder, a popular spice used in Ayurvedic medicine that dates back thousands of years. This has relevance insomuch as Ayurvedic formulas are integral to Yield Growth’s fundamental business model to use ancient methods for modern healing.
To lend a little more color as to the opportunity for a new player in the mushroom market, Four Sigmatic, a functional mushroom product upstart founded in 2012, generates $61.7 million in annual revenue, according to Crunchbase.
As part of the license agreement in which Yield Growth granted Flourish rights to mushroom product formulations, Flourish has paid Yield Growth $1.8 million in share consideration (90M shares). An additional $1.2 million in cash is due over the next 24 months, but it is subject to modifications based upon Flourish becoming a public entity. In that same lane, the 90 million shares of stock will be held in escrow until Flourish completes an initial public offering and, even then, only be slowly released over three years.
With the license in hand and new products in the works, Flourish has moved forward with aligning international distribution. This month a one-year exclusive distribution agreement was forged with Eurolife Brands that will take the Flourish mushroom coffee line to Germany, Switzerland and the United Kingdom. Furthermore, the agreement provides for Eurolife to have non-exclusive rights to additional territories for a period of two years as well as laying out a plan to fold the new coffee mixes into Eurolife’s ecommerce platform during the second quarter of 2020.
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.